BRADLEY LETTERHEAD]Merger Agreement • January 17th, 2008 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations
As you are aware, Bradley has entered into a merger agreement with Phase Merger Sub Inc. (“Merger Sub”), a Delaware corporation and a wholly owned subsidiary of Nycomed US Inc. (“Nycomed”). Pursuant to the terms of the merger agreement, each outstanding share of Bradley common stock will be converted into the right to receive $20.00 in cash.
